Heart Medication Shows Potential as Treatment for Alcohol Use Disorder

December 7, 2022 by Dan McCue
Heart Medication Shows Potential as Treatment for Alcohol Use Disorder
(Photo by Alexander Grey via UnSplash)

WASHINGTON – A medication for heart problems and high blood pressure may also be effective for treating alcohol use disorder, according to a new study by researchers at the National Institutes of Health and their colleagues.

The study presents converging evidence from experiments in mice and rats, as well as a cohort study in humans, suggesting that the medication, spironolactone, may play a role in reducing alcohol drinking.

The research was led by scientists at the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, and Yale School of Medicine. 

The findings were published in the journal Molecular Psychiatry.

“Combining findings across three species and different types of research studies, and then seeing similarities in those data, gives us confidence that we are onto something potentially important scientifically and clinically,” said Dr. Lorenzo Leggio, Ph.D., chief of the Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, a joint laboratory of NIDA and NIAAA, in a written statement.

Leggio, one of the senior authors of the study, went on to say the findings support further study of spironolactone as a potential treatment for alcohol use disorder, a medical condition that affects millions of people in the U.S.

Currently there are three medications approved for alcohol use disorder in the United States. But given the diverse biological processes that contribute to alcohol use disorder, new medications are needed to provide a broader spectrum of treatment options. 

Previous research has shown that mineralocorticoid receptors, which are located throughout the brain and other organs and help regulate fluid and electrolyte balance in the body, might play a role in alcohol use and craving.

Preclinical research suggests that higher mineralocorticoid receptor signaling contributes to increased alcohol consumption.

The current study sought to expand this line of research by testing spironolactone, a medication with multiple actions, including blocking mineralocorticoid receptors. Spironolactone is used in clinical practice as a diuretic and to treat conditions like heart problems and high blood pressure.

In experiments conducted in mouse and rat models of excessive alcohol drinking, NIAAA and NIDA researchers led by co-senior author Leandro Vendruscolo, Pharm.D., Ph.D., from NIDA found that increasing doses of spironolactone decreased alcohol consumption in male and female animals, without causing movement or coordination problems, and without affecting their food or water intake.

In a parallel study, researchers led by co-senior author Amy C. Justice, M.D., Ph.D., of the Yale School of Medicine, examined health records of a large sample of people from the U.S. Veterans Affairs health care system to assess potential changes in alcohol drinking after spironolactone was prescribed for its current clinical indications (for example, heart problems, high blood pressure).

They found a significant association between spironolactone treatment and reduction in self-reported alcohol consumption, as measured by the Alcohol Use Disorders Identification Test-Consumption, a screening tool. 

Of note, the largest effects were observed among those who reported hazardous/heavy episodic alcohol consumption before starting spironolactone treatment.

“These are very encouraging findings,” said NIAAA Director George F. Koob, Ph.D., a co-author of the study, in a written statement. 

“Taken together, the present study argues for conducting randomized, controlled studies of spironolactone in people with alcohol use disorder to further assess its safety and potential efficacy in this population, as well as additional work to understand how spironolactone may reduce alcohol drinking,” Koob said.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue

A+
a-
  • heart medication
  • Spironolactone
  • In The News

    Health

    Voting

    Mental Health

    November 15, 2023
    by Dan McCue
    Dr. Ruth Named NY’s First Ambassador to Loneliness

    ALBANY, N.Y. — Dr. Ruth Westheimer, the iconic media personality who rocketed to fame as the nation’s sex therapist in... Read More

    ALBANY, N.Y. — Dr. Ruth Westheimer, the iconic media personality who rocketed to fame as the nation’s sex therapist in the 1980s, now has a new title to add to her resume: She’s now New York’s — and by extension, the United States’ — first ambassador... Read More

    Top US Accident Investigator Says Close Calls Between Planes Show Aviation Is Under Stress

    The nation’s top accident investigator said Thursday that a surge in close calls between planes at U.S. airports this year... Read More

    The nation’s top accident investigator said Thursday that a surge in close calls between planes at U.S. airports this year is a "clear warning sign” that the aviation system is under stress. “While these events are incredibly rare, our safety system is showing clear signs of... Read More

    November 7, 2023
    by Jesse Zucker
    Exercise and Nutrition Tips for Seasonal Affective Disorder

    WASHINGTON — Welcome to November. We’re well into autumn and it’s time to “fall back” — daylight saving time has... Read More

    WASHINGTON — Welcome to November. We’re well into autumn and it’s time to “fall back” — daylight saving time has ended, there’s plenty of beauty to see and holidays to look forward to. But as the weather gets colder and the sun sets earlier, many people... Read More

    November 7, 2023
    by Tom Ramstack
    Whistleblower Says Meta Execs Knew Social Media Can Harm Kids

    WASHINGTON — A whistleblower former employee of Meta Platforms Inc. told a Senate panel Tuesday that top executives of the... Read More

    WASHINGTON — A whistleblower former employee of Meta Platforms Inc. told a Senate panel Tuesday that top executives of the social media giant knew their Facebook platform harmed young people but covered it up to avoid interfering with their profits. He said he showed statistics to... Read More

    November 1, 2023
    by Dan McCue
    First Federal Campaign Launched to Tackle Health Care Workers’ Burnout

    WASHINGTON — A new federal campaign aims to provide hospital leaders with the critical, evidence-based resources they need to improve... Read More

    WASHINGTON — A new federal campaign aims to provide hospital leaders with the critical, evidence-based resources they need to improve workplace policies and reduce burnout among their staff of health care professionals. As previously reported in The Well News, physician burnout has reached a crisis stage... Read More

    October 30, 2023
    by Jesse Zucker
    Enjoy the Best Fall Foliage on These Outdoor Exercise Routes

    WASHINGTON — Attention fall enthusiasts: we’ve reached peak foliage season in Washington, D.C.! The end of October into November is... Read More

    WASHINGTON — Attention fall enthusiasts: we’ve reached peak foliage season in Washington, D.C.! The end of October into November is the best time to see the brightest orange, yellow, and red leaves on trees. They’ll hang around a little longer, but all too soon will change... Read More

    News From The Well
    scroll top